Dihydroberberine is a novel and potent inhibitor of pancreatic lipase with anti-inflammatory, anti-atherosclerotic, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces heat shock protein 90 (Hsp90) expression and its interaction with hERG.

纯度：≥98%

CAS：483-15-8